The report of global caspofungin market by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines) Infection Type (Superficial Antifungal Infections, Systemic Antifungal Infections) Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis) Dosage Forms (Powders, Ointments, Drugs) and Region (Asia Pacific, North America, Europe, Latin America, and Middle East Africa) is expected to reach US$ 477.84 Mn by 2026, at a CAGR of XX% during a forecast period.
Rise in incidence of chronic diseases i.e., increase in the geriatric population, surge in awareness about advanced therapies, cancer and diabetes are factors projected to boost the global caspofungin market from 2019 to 2026. Caspofungin (Cancidas) is an antifungal drug that works by inhibiting the enzyme (1→3)-β-D-glucan synthase, thereby disturbing the integrity of the fungal cell wall. The requirement for the antifungal drugs market are accelerate by rising incidence of fungal infection, rise in awareness levels pertaining to myriad fungal infections, and increase in demand for the drugs to combat the related diseases. The presence of counterfeit drugs and resistance toward antifungal drugs are restraining the market growth at global level.
Therapeutic Indications segment is expected to grow at the highest XX% CAGR during the forecast period.
The preferred use of caspofungin over other antifungals in certain diseases is expected to impel the market during the upcoming period. Therapeutic indications are an explanation of the disease to be treated with a medicine, and the population for which the medicine is intended. They contain the specifics about the disease, and restrictions to the patient population such as age, and whether the medicine is intended for symptom relief, cure or prevention, or whether it is for diagnostic use only.
The North America dominated the global caspofungin market in 2018
North America and Europe held for leading shares of the caspofungin market in 2018 owing to presence of key pharmaceutical companies and large patient population. The market in Asia Pacific is projected to grow at the highest CAGR of XX% during the forecast period owing to rapidly improving health care facilities in countries such as India, China, South Korea, and Malaysia. China dominated the caspofungin market in 2018 and market in India is anticipated to expand at a significant CAGR of XX% during the upcoming period. Furthermore, increase in investment by leading players and introduction of generics by other players are expected to drive the growth of the market in the region. The market in Latin America and Middle East & Africa is likely to expand at a steady pace during the forecast period.
Key players operating the global caspofungin market are Teva Pharmaceutical Industries Ltd., Mylan N.V , Merck & Co., Inc., Fresenius SE & Co. KGaA , Gland Pharma Limited, and Xellia Pharmaceuticals. Aspergillus, Pharmacompass, Kwality Pharmaceuticals Limited, SVAK Life Sciences, Centrient Pharmaceuticals., Alvogen, Clinical Trials Arena, ALTAN pharma
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the global caspofungin market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the global caspofungin market. The driving forces, as well as considerable restraints, have been explained in depth. in addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain global caspofungin market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Caspofungin Market”
https://www.maximizemarketresearch.com/market-report/global-caspofungin-market/36158/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908